[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 514 Agreed to Senate (ATS)]

<DOC>






119th CONGRESS
  1st Session
S. RES. 514

       Designating November 2025 as ``American Diabetes Month''.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           November 20, 2025

  Mrs. Shaheen (for herself and Ms. Collins) submitted the following 
             resolution; which was considered and agreed to

_______________________________________________________________________

                               RESOLUTION


 
       Designating November 2025 as ``American Diabetes Month''.

Whereas, according to the Centers for Disease Control and Prevention--

    (1) an estimated 38,400,000 individuals in the United States have 
diabetes; and

    (2) an estimated 97,600,000 individuals in the United States who are 18 
years of age or older have prediabetes;

Whereas diabetes is a serious chronic condition that affects individuals of 
        every age, race, ethnicity, and income level;
Whereas the Centers for Disease Control and Prevention reports that--

    (1) Hispanic, Black, Asian, American Indian, and Alaska Native adults 
in the United States are disproportionately affected by diabetes and 
develop the disease at much higher rates than the general population of the 
United States; and

    (2) an estimated 23 percent of individuals with diabetes in the United 
States have not yet been diagnosed with the disease;

Whereas, in the United States, an estimated 11.6 percent of the population, 
        including 29.2 percent of individuals who are 65 years of age or older, 
        have diabetes;
Whereas, of the approximately 15,800,000 veterans in the United States, nearly 1 
        in 4 receiving care in the Department of Veterans Affairs system receive 
        treatment for diabetes, representing more than double the rate found in 
        the general population;
Whereas the risk of developing type 2 diabetes at some point in life is 40 
        percent for adults in the United States;
Whereas, according to the American Diabetes Association--

    (1) in 2022, the estimated direct and indirect medical costs in the 
United States for cases of diagnosed diabetes was $412,900,000,000; and

    (2) as insulin prices remain high for some patients, 1 in 4 individuals 
using insulin report reducing use due to insulin cost;

Whereas the American Diabetes Association reports that, in 2022, care for 
        individuals with diagnosed diabetes accounted for 1 in 4 health care 
        dollars in the United States;
Whereas medical costs are estimated to be 2.6 times higher for individuals in 
        the United States with diabetes than those without diabetes;
Whereas, as of November 2025, a cure for diabetes does not exist;
Whereas there are successful means to reduce the incidence, and delay the onset, 
        of type 2 diabetes;
Whereas, with proper management and treatment, individuals with diabetes live 
        healthy and productive lives; and
Whereas individuals in the United States celebrate American Diabetes Month in 
        November: Now, therefore, be it
    Resolved, That the Senate--
            (1) designates November 2025 as ``American Diabetes 
        Month''; and
            (2) supports the goals and ideals of American Diabetes 
        Month, including--
                    (A) encouraging individuals in the United States to 
                fight diabetes through public awareness of prevention 
                and treatment options;
                    (B) enhancing diabetes education;
                    (C) recognizing the importance of awareness and 
                early detection, including awareness of symptoms and 
                risk factors such as--
                            (i) being--
                                    (I) older than 45 years of age; or
                                    (II) overweight; and
                            (ii) having--
                                    (I) a particular racial and ethnic 
                                background;
                                    (II) a low level of physical 
                                activity;
                                    (III) high blood pressure;
                                    (IV) a family history of diabetes; 
                                or
                                    (V) a history of diabetes during 
                                pregnancy;
                    (D) supporting a decrease in the prevalence of type 
                1, type 2, and gestational diabetes in the United 
                States through research, treatment, and prevention; and
                    (E) recognizing the importance of addressing 
                barriers to health care that--
                            (i) leave many communities at a heightened 
                        risk for diabetes; and
                            (ii) limit access to health care resources 
                        that are needed to effectively prevent the 
                        onset, and to manage the condition, of 
                        diabetes.
                                 <all>